Technical Analysis for RGDXQ - Response Genetics

Grade Last Price % Change Price Change
grade C 0.0022 -4.35% -0.0001
RGDXQ closed down 4.35 percent on Friday, August 23, 2019, on 32 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical RGDXQ trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction -4.35%
Narrow Range Bar Range Contraction -4.35%
Wide Bands Range Expansion -4.35%
Fell Below 20 DMA Bearish -4.35%
Fell Below 50 DMA Bearish -4.35%

Older signals for RGDXQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available from each patient sample. The Company's platforms include analysis of single biomarkers using the polymerase chain reaction method, as well as gene interrogation using microarray methods and fluorescence in situ hybridization (FISH) from paraffin or frozen tissue specimens. The Company is engaged in selling ResponseDX diagnostic testing products. The Company provides pharmacogenomic clinical trial testing services to pharmaceutical companies in the United States, Asia and Europe.
Biotechnology Branches Of Biology Cancer Pharmaceutical Life Sciences Biology Treatment Of Cancer Molecular Biology Biomarkers Genomics Dna Chip Medical Signs Hybridization Pharmacogenomics
Is RGDXQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.0074
52 Week Low 0.0001
Average Volume 224,860
200-Day Moving Average 0.0017
50-Day Moving Average 0.0024
20-Day Moving Average 0.0024
10-Day Moving Average 0.0024
Average True Range 0.0007
ADX 24.03
+DI 28.3019
-DI 22.6415
Chandelier Exit (Long, 3 ATRs ) 0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0041
Upper Bollinger Band 0.0029
Lower Bollinger Band 0.0019
Percent B (%b) 0.3
BandWidth 41.666667
MACD Line 0.0
MACD Signal Line 0.0001
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0024
Resistance 3 (R3) 0.0024 0.0023 0.0023
Resistance 2 (R2) 0.0023 0.0023 0.0023 0.0023
Resistance 1 (R1) 0.0023 0.0023 0.0023 0.0023 0.0023
Pivot Point 0.0022 0.0022 0.0022 0.0022 0.0022
Support 1 (S1) 0.0022 0.0022 0.0022 0.0022 0.0021
Support 2 (S2) 0.0021 0.0022 0.0021 0.0021
Support 3 (S3) 0.0021 0.0021 0.0021
Support 4 (S4) 0.0021